Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation.

[1]  E. Erdei,et al.  A new understanding in the epidemiology of melanoma , 2010, Expert review of anticancer therapy.

[2]  J. Girard,et al.  Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids. , 2009, The Biochemical journal.

[3]  H. Waterham,et al.  Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency. , 2005, Molecular genetics and metabolism.

[4]  H. Karlic,et al.  Dietary L-carnitine Stimulates Carnitine Acyltransferases in the Liver of Aged Rats , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.